IPMC 2025 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2025) scheduled during March 13-15, 2025 in Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at precision-medicine@magnusconference.com or call + 1 (702) 988 2320.
3rd Edition of International Precision Medicine Conference
March 13-15, 2025
Rare Diseases/Disorders and Orphan Drugs
A disease or condition is considered rare if it affects fewer than one in every 2,000 people in the general population. There are currently about 6,000 known rare diseases, and new ones are being discovered on a regular basis in scientific literature. Word ‘Orphan’ is derived from the Greek term ‘orphanos’, which refers to a child who has lost one or both parents, as well as an adult who has lost a child. Orphan drugs are medications used to diagnose, prevent, or cure rare diseases that are life-threatening or disabling. They're called "orphans" because the pharmaceutical business has little interest in developing and marketing medications for a small proportion of patients with extremely rare diseases under normal market conditions.
- FDA approved drugs
- Efficacy of orphan drugs
Alain Chapel
Institute Of Radiological Protection And Nuclear Safety, France
Sergio Marchini
Humanitas Research Hospital, Italy
Michael Thompson
University of Toronto, CanadaSubmit your abstract Today
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to secure the human healthcare, wellness and biosafety through the view of public health, network-driven healthcare services and lifestyle management
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Potential serum biomarkers for early detection of diabetic nephropathy
Tarek Kamal Motawi , Cairo University, Egypt
Title : Personalized & Precision Medicine (PPM) as a Unique Avenue to have the Healthcare Model Renewed to Secure the National Biosafety: Through The View of Obesity Nutrition to Reach the Personalized Diet Harmony and Lifestyle Wellness
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Personalized and Precision Medicine (PPM) thought The View of Reproductive Healthcare and Natural Family Planning: An Option for clinicians and caregivers realize the potential of genomics-informed care to secure the Individualized Human Biosafety
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : 3D Bioprinting complicated large organs with a vascular system
Vyacheslav R Shulunov, Russian Academy of Science, Russian Federation
Title : Persian medicine, medicine based on temperament
Mehdi Zarvandi, Golestan University of Medical Sciences, Iran (Islamic Republic of)